Ropsacitinib
CAS No. 2127109-84-4
Ropsacitinib( —— )
Catalog No. M33158 CAS No. 2127109-84-4
Ropsacitinib (PF-06826647) is a selective TYK2 inhibitor, which binds to TYK2 catalytically active JH1 domain (IC50: 17 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 347 | In Stock |
|
| 5MG | 492 | In Stock |
|
| 10MG | 712 | In Stock |
|
| 25MG | 1102 | In Stock |
|
| 50MG | 1460 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRopsacitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionRopsacitinib (PF-06826647) is a selective TYK2 inhibitor, which binds to TYK2 catalytically active JH1 domain (IC50: 17 nM).
-
DescriptionRopsacitinib (PF-06826647) is a selective TYK2 inhibitor, which binds to TYK2 catalytically active JH1 domain (IC50: 17 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorTyrosine Kinases
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2127109-84-4
-
Formula Weight383.41
-
Molecular FormulaC20H17N9
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C#N)[C@@]1(C[C@H](C#N)C1)N2C=C(C=N2)C=3C=4N(C=C(N3)C=5C=NN(C)C5)N=CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Glycolic acid
Glycolic acid is an inhibitor of tyrosinase suppressing melanin formationand used in skincare products
-
EHT 1610
EHT 1610 (EHT 5372) is a potent inhibitor of DYRK, with an IC50 of 0.36 nM and 0.59 nM for DYRK1A and DYRK1B, respectively.
-
Flanvotumab
Flanvotumab (IMC-20D7S) is a humanized monoclonal antibody targeting tyrosinase-related protein (TYRP1), exhibiting potent antitumor activity through natural killer-mediated and antibody-dependent cell-mediated cytotoxicity (ADCC).
Cart
sales@molnova.com